Beta Bionics Inc (BBNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,298 | -21,895 | -73,200 | -59,734 | -45,525 |
| Depreciation Amortization | 2,286 | 987 | 2,875 | 1,940 | -473 |
| Accounts receivable | -951 | 1,368 | -5,162 | 433 | 601 |
| Accounts payable and accrued liabilities | -471 | -3,333 | 2,098 | 1,571 | 471 |
| Other Working Capital | -7,701 | -8,214 | -8,992 | -7,654 | -7,971 |
| Other Operating Activity | 13,681 | 7,255 | 31,456 | 21,146 | 19,328 |
| Operating Cash Flow | $-38,454 | $-23,832 | $-50,925 | $-42,298 | $-33,569 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 96,000 | 48,000 | 164,703 | -114,772 | -139,768 |
| PPE Investments | -2,416 | -1,377 | -282,035 | -3,394 | -2,112 |
| Purchase Of Investment | -44,812 | -24,784 | -45,473 | -45,297 | -31,069 |
| Investing Cash Flow | $48,772 | $21,839 | $-162,805 | $-163,463 | $-172,949 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,424 | 623 | 214,874 | 213,814 | 211,161 |
| Financing Cash Flow | $2,424 | $623 | $214,874 | $213,814 | $211,161 |
| Beginning Cash Position | 31,676 | 31,676 | 30,532 | 30,532 | 30,532 |
| End Cash Position | 44,418 | 30,306 | 31,676 | 38,585 | 35,175 |
| Net Cash Flow | $12,742 | $-1,370 | $1,144 | $8,053 | $4,643 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,454 | -23,832 | -50,925 | -42,298 | -33,569 |
| Capital Expenditure | -2,416 | -1,377 | -282,035 | -3,394 | -2,112 |
| Free Cash Flow | -40,870 | -25,209 | -332,960 | -45,692 | -35,681 |